tirzepatide 2.5 dose Zepbound mg/0.5 mL injection (single-dose vial) Images Compounded TIRZEPATIDE Single-dose Wellness Shots

Overall, tirzepatide demonstrated superior efficacy in weight and metabolic improvements compared to semaglutide in adults with obesity or overweight and comorbidities with similar safety profiles

* Although this drug, which treats migraines, is not a GLP-1, it is part of the agreement

Also occasionally used for thigh injections in patients with substantial leg adipose tissue

If pregnancy is recognized during treatment, the medication should be discontinued immediately and the healthcare provider contacted promptly

This is also true of other GLP-1 medications like Wegovy, which also contains the active ingredient semaglutide and is made by the same manufacturer, Novo Nordisk